Les Rosoph

Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial

Kim Papp, Jennifer Clay Cather, Les Rosoph et al. · The Lancet · 2012 · 277 citations

Medicine, Severe Psoriasis, Clinical Dermatology +3

Evidence that a neutrophil–keratinocyte crosstalk is an early target of <scp>IL</scp>‐17A inhibition in psoriasis

Kristian Reich, Kim Papp, Robert Matheson et al. · Experimental Dermatology · 2015 · 197 citations · Full text

Immunodeficiencies, Immune Regulation, Immunology +20

Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence

Kim Papp, Darryl Toth, Les Rosoph · BMC Dermatology · 2006 · 13 citations · Full text

Open-Label Study to Assess the Safety and Efficacy of Imiquimod 5% Cream Applied Once Daily Three Times per Week in Cycles for Treatment of Actinic Keratoses on the Head

Jason K. Rivers, Les Rosoph, Nathalie Provost et al. · Journal of Cutaneous Medicine and Surgery · 2008 · 12 citations

Summer Camp Health Initiative: An Overview of Injury and Illness in Two Canadian Summer Camps

Adam Handler, Mattan Lustgarten, Arielle Zahavi et al. · Cureus · 2018 · 12 citations · Full text